FindTrial
Sign In

A clinical study to compare the efficacy of Levobupivacaine with Magnesium sulphate versus Levobupivacaine alone in supraclavicular brachial plexus block for upper limb surgeries

A Comparitive study to evaluate the efficacy of 0.5% Lvobupivacaine with Magnesium sulphate versus 0.5% Levobupivacaine alone in Ultrasound guided Supraclavicular Brachial Plexus block for upper limb surgeries

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/02/040573
Enrollment
60
Registered
2022-02-23
Start date
Unknown
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: T223- Burn of third degree of shoulder and upper limb, except wrist and hand Health Condition 2: S424- Fracture of lower end of humerus Health Condition 3: S423- Fracture of shaft of humerus Health Condition 4: O- Medical and Surgical Health Condition 5: O- Medical and Surgical Health Condition 6: S529- Unspecified fracture of forearm Health Condition 7: S599- Unspecified injury of elbow and forearm

Interventions

Intervention1: 0.5% INJ LEVOBUPIVACAINE WITH INJ MAGNESIUM SULPHATE: 0.5% INJ LEVOBUPIVACAINE 18ml WITH INJ MAGNESIUM SULPHATE 150mg 2ml. The block will be assessed till regain of sensory and motor bl

Sponsors

Dr Deeksha R Malkhedkar
Lead Sponsor
Dr SHOBHA D
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients providing written informed consent voluntarily 2) American Society of Anaesthesiologists class 1 and 2 3) Patients height 150-180cm and weight 50-80kg. 4) Patients undergoing elective upper limb surgeries.

Exclusion criteria

Exclusion criteria: 1) Patients not willing to give written informed consent 2) Patients with any contraindications for peripheral nerve block. 3) Allergic to study drug. 4) Coagulation disorders 5) Respiratory insufficiency

Design outcomes

Primary

MeasureTime frame
Duration of analgesiaTimepoint: Duration of analgesia postoperatively 0hr, 2hr, 6hr, 12hr, 20hr and 24hr—

Secondary

MeasureTime frame
Duration of motor blockTimepoint: Time taken between injection to complete return of motor power. Post operative 0hr, 2hr, 6hr, 12hr, 20hr and 24hr;Duration of sensory blockTimepoint: Time taken between injection of drug and appearance of pain requiring analgesia. Post operative 0hr, 2hr, 6hr, 12hr, 20hr and 24hr;Time of onset of motor blockadeTimepoint: From end of injection of drug to onset of complete loss of motor power. 0min, 5min, 10min, 15min, 20min, 25min, 30min;Time of onset of sensory blockadeTimepoint: From end of injection of drug to first dull response to pinprick. 0min, 5min, 10min, 15min, 20min, 25min, 30min—

Countries

India

Contacts

Public ContactDr SHOBHA D

Bangalore Medical College and Research Institute, Bangalore

dr_shobhadayal@yahoo.co.in9972868611

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026